World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
55047
World Ranking
5268
National Ranking
2843

Overview

David S. Alberts is affiliated with the University of Arizona in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Oncology, Surgery, Obstetrics and Gynecology, Reproductive Medicine, and Pulmonary and Respiratory Medicine.

Their work covers a range of topics including:

  • Ovarian cancer diagnosis and treatment
  • Cancer survivorship and care
  • Endometrial and Cervical Cancer Treatments
  • Intraperitoneal and Appendiceal Malignancies
  • Lymphatic System and Diseases
  • Systemic Sclerosis and Related Diseases
  • Colorectal and Anal Carcinomas

David S. Alberts has published in several scientific venues. The most frequent publication venues include:

  • Gynecologic Oncology
  • UNC Libraries
  • Journal of Clinical Oncology
  • Journal of Biomedical Optics
  • Colorectal Cancer

Examples of recent papers authored or coauthored by David S. Alberts include:

  • Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix, 2023, Journal of Clinical Oncology
  • GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function, 2020, Gynecologic Oncology
  • Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors, 2023, Gynecologic Oncology
  • Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes, 2021, Journal of Biomedical Optics
  • Characteristics and risk factors for early-onset metachronous colorectal adenoma, 2020, Colorectal Cancer

The scientist often collaborates with several coauthors, including:

  • Joan L. Walker
  • Linda Van Le
  • Paul DiSilvestro
  • Saketh R. Guntupalli
  • Michael Yozwiak

Best Publications

  • Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix

    William A. Peters;P.Y. Liu;Rolland J. Barrett;Richard J. Stock

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P.S.J. Meltzer;Y.D. Chen;Y. Jiang

  • Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.

    Janine G. Einspahr;David S. Alberts;Susan M. Gapstur;Roberd M. Bostick

  • Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

    David S. Alberts;P. Y. Liu;Edward V. Hannigan;Robert O'Toole

  • Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

    Maurie Markman;Brian N. Bundy;David S. Alberts;Jeffrey M. Fowler

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

    Sydney E. Salmon;Anne W. Hamburger;Barbara Soehnlen;Brian G. M. Durie

  • Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials

    Claire Vale;Jayne F. Tierney;Lesley A. Stewart;Mark Brady

  • Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

    George Pettit;S. B. Singh;E. Hamel;C. M. Lin

  • Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

    Michael A. Bookman;Mark F. Brady;William P. McGuire;Peter G. Harper

  • Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

    H-H. Sherry Chow;Yan Cai;Iman A. Hakim;James A. Crowell

  • Ovarian Cancer: Screening, Treatment, and Follow-up

    Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld

  • A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy

    María Elena Martínez;John A. Baron;David A. Lieberman;Arthur Schatzkin

  • MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer

    Lanlan Shen;Yutaka Kondo;Gary L. Rosner;Lianchun Xiao

  • Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial

    Maurie Markman;P.Y. Liu;Sharon Wilczynski;Bradley Monk

  • Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis

    Gary A. Piazza;Alanna L. Kulchak Rahm;Mary Krutzsch;Gerhard Sperl

  • Phase I Pharmacokinetic Study of Tea Polyphenols following Single-dose Administration of Epigallocatechin Gallate and Polyphenon E

    H-H. Sherry Chow;Yan Cai;David S. Alberts;Iman Hakim

  • Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

    Joyce A. O’Shaughnessy;Gary J. Kelloff;Gary B. Gordon;Andrew J. Dannenberg

  • Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals

    H-H. Sherry Chow;Iman A. Hakim;Donna R. Vining;James A. Crowell

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P. Meltzer;Y. Chen;Y. Jiang

Frequent Co-Authors

Frank L. Meyskens
Frank L. Meyskens University of California, Irvine
Sydney E. Salmon
Sydney E. Salmon University of Arizona
James R. Marshall
James R. Marshall Roswell Park Cancer Institute
Zigang Dong
Zigang Dong University of Minnesota
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Dennis J. Ahnen
Dennis J. Ahnen University of Colorado Denver
Ann M. Bode
Ann M. Bode University of Minnesota
Emanuel F. Petricoin
Emanuel F. Petricoin George Mason University
Thomas P. Davis
Thomas P. Davis University of Arizona
Anna R. Giuliano
Anna R. Giuliano University of South Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine but want flexible educational options, several online pathways can help you advance in the healthcare field. For those more interested in healthcare management than direct patient care, consider cahme accredited online healthcare administration programs. These programs are designed to give you the leadership skills needed for high-level roles in hospitals and clinics, often without the need to relocate or change your work schedule.

Registered nurses looking to further their education can pursue rn to bsn programs no clinicals, which allow RNs to earn advanced credentials 100% online, without additional in-person practicums.

For nurses aiming for the highest clinical degree, accelerated dnp programs online make it possible to fast-track a Doctor of Nursing Practice in as little as one year, depending on your background. Certain online dnp programs without clinicals can also be an option, offering advanced leadership and policy education without on-site requirements.

These online options support diverse medical and healthcare goals, maximizing flexibility for working professionals and students worldwide.

Best Scientists Citing David S. Alberts

Trending Scientists

Recently Published Articles